MASSA, FEDERICO
MASSA, FEDERICO
100009 - Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era
2022-01-01 Ruscitti, Federica; Origone, Paola; Rosti, Giulia; Trevisan, Lucia; Marchese, Roberta; Brugnolo, Andrea; Massa, Federico; Castellini, Paola; Mandich, Paola
A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection
2021-01-01 Grisanti, S. G.; Franciotta, D.; Garnero, M.; Zuppa, A.; Massa, F.; Mobilia, E. M.; Pesce, G.; Schenone, A.; Benedetti, L.
Abnormal sweating and “skin flushing” as possible predictive factor for treatment related fluctuations in Guillain-Barré syndrome: a case series and a review of the literature
2021-01-01 Demichelis, C.; Grisanti, S.; Massa, F.; Serrati, C.; Beronio, A.; Mannironi, A.; Mobilia, E.; Briani, C.; Schenone, A.; Benedetti, L.
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease
2019-01-01 De Carli, Fabrizio; Nobili, Flavio; Pagani, Marco; Bauckneht, Matteo; Massa, Federico; Grazzini, Matteo; Jonsson, Cathrine; Peira, Enrico; Morbelli, Silvia; Arnaldi, Dario.
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease
2022-01-01 Massa, F.; Chincarini, A.; Bauckneht, M.; Raffa, S.; Peira, E.; Arnaldi, D.; Pardini, M.; Pagani, M.; Orso, B.; Donegani, M. I.; Brugnolo, A.; Biassoni, E.; Mattioli, P.; Girtler, N.; Guerra, U. P.; Morbelli, S.; Nobili, F.
Alzheimer's disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era
2024-01-01 Sofia, Luca; Massa, Federico; Pardini, Matteo; Arnaldi, Dario; Bauckneht, Matteo; Morbelli, Silvia
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease
2020-01-01 Orso, B.; Arnaldi, D.; Fama, F.; Girtler, N.; Brugnolo, A.; Doglione, E.; Filippi, L.; Massa, F.; Peira, E.; Bauckneht, M.; Morbelli, S.; Nobili, F.; Pardini, M.
Anti-LGI1 encephalitis and Langerhans cell histiocytosis: two associated entities? A case report
2024-01-01 Cerne, Denise; Massa, Federico; Mora, Marco; Morbelli, Silvia; Roccatagliata, Luca; Rebella, Giacomo; Villani, Flavio; Bozzano, Federica; Uccelli, Antonio; Benedetti, Luana; Cabona, Corrado
Autoimmune encephalitis: what the radiologist needs to know
2024-01-01 Sanvito, F.; Pichiecchio, A.; Paoletti, M.; Rebella, G.; Resaz, M.; Benedetti, L.; Massa, F.; Morbelli, S.; Caverzasi, E.; Asteggiano, C.; Businaro, P.; Masciocchi, S.; Castellan, L.; Franciotta, D.; Gastaldi, M.; Roccatagliata, L.
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy.
2020-01-01 Massa, F; Zuppa, A; Pesce, G; Demichelis, C; Bergamaschi, M; Garnero, M; Briani, C; Ferrari, S; Schenone, A; Benedetti, L
Brain metabolic correlates of persistent olfactory dysfunction after sars-cov2 infection
2021-01-01 Donegani, M. I.; Miceli, A.; Pardini, M.; Bauckneht, M.; Chiola, S.; Pennone, M.; Marini, C.; Massa, F.; Raffa, S.; Ferrarazzo, G.; Arnaldi, D.; Sambuceti, G.; Nobili, F.; Morbelli, S.
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)
2021-01-01 Brugnolo, Andrea; Girtler, Nicola; Doglione, Elisa; Orso, Beatrice; Massa, Federico; Donegani, Maria Isabella; Bauckneht, Matteo; Morbelli, Silvia; Arnaldi, Dario; Nobili, Flavio; Pardini, Matteo
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS
2022-01-01 Bellucci, Margherita; Germano, Francesco; Grisanti, Stefano; Castellano, Chiara; Tazza, Francesco; Mobilia, Emanuela Maria; Visigalli, Davide; Novi, Giovanni; Massa, Federico; Rossi, Silvia; Durando, Paolo; Cabona, Corrado; Schenone, Angelo; Franciotta, Diego; Benedetti, Luana
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease
2023-01-01 Massa, F.; Martinuzzo, C.; Gomez de San Jose, N.; Pelagotti, V.; Kreshpa, W.; Abu-Rumeileh, S.; Barba, L.; Mattioli, P.; Orso, B.; Brugnolo, A.; Girtler, N.; Vigo, T.; Arnaldi, D.; Serrati, C.; Uccelli, A.; Morbelli, S.; Chincarini, A.; Otto, M.; Pardini, M.
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease
2022-01-01 Barba, L.; Abu Rumeileh, S.; Bellomo, G.; Paolini Paoletti, F.; Halbgebauer, S.; Oeckl, P.; Steinacker, P.; Massa, F.; Gaetani, L.; Parnetti, L.; Otto, M.
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
2024-01-01 Barba, Lorenzo; Abu-Rumeileh, Samir; Barthel, Henryk; Massa, Federico; Foschi, Matteo; Bellomo, Giovanni; Gaetani, Lorenzo; Rudolf Thal, Dietmar; Parnetti, Lucilla; Otto, Markus
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia
2020-01-01 Orso, B; Mattei, C; Arnaldi, D; Massa, F; Serafini, G; Plantone, D; Doglione, E; Grafman, J; Nobili, F; Pardini, M.
Clinical utility and research frontiers of neuroimaging in movement disorders
2017-01-01 Nobili, FLAVIO MARIANO; Westman, Eric; Kogan, Rosalie V; Pereira, Joana B; Massa, Federico; Grazzini, Matteo; Meles, Sanne K; Leenders, Klaus L.
Clinical versus biomarker-based diagnosis of neurocognitive disorders – Authors' reply
2024-01-01 Massa, F.; Villain, N.; Cotta Ramusino, M.; Frisoni, G. B.
Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy
2022-01-01 Mattioli, Pietro; Pardini, Matteo; Girtler, NICOLA GIOVANNI; Brugnolo, Andrea; Orso, Beatrice; Donniaquio, Andrea; Calizzano, Francesco; Mancini, Raffaele; Massa, Federico; Terzaghi, Michele; Bauckneht, Matteo; Morbelli, SILVIA DANIELA; Sambuceti, Gianmario; Nobili, FLAVIO MARIANO; Arnaldi, Dario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era | 1-gen-2022 | Ruscitti, Federica; Origone, Paola; Rosti, Giulia; Trevisan, Lucia; Marchese, Roberta; Brugnolo, Andrea; Massa, Federico; Castellini, Paola; Mandich, Paola | |
| A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection | 1-gen-2021 | Grisanti, S. G.; Franciotta, D.; Garnero, M.; Zuppa, A.; Massa, F.; Mobilia, E. M.; Pesce, G.; Schenone, A.; Benedetti, L. | |
| Abnormal sweating and “skin flushing” as possible predictive factor for treatment related fluctuations in Guillain-Barré syndrome: a case series and a review of the literature | 1-gen-2021 | Demichelis, C.; Grisanti, S.; Massa, F.; Serrati, C.; Beronio, A.; Mannironi, A.; Mobilia, E.; Briani, C.; Schenone, A.; Benedetti, L. | |
| Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease | 1-gen-2019 | De Carli, Fabrizio; Nobili, Flavio; Pagani, Marco; Bauckneht, Matteo; Massa, Federico; Grazzini, Matteo; Jonsson, Cathrine; Peira, Enrico; Morbelli, Silvia; Arnaldi, Dario. | |
| Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease | 1-gen-2022 | Massa, F.; Chincarini, A.; Bauckneht, M.; Raffa, S.; Peira, E.; Arnaldi, D.; Pardini, M.; Pagani, M.; Orso, B.; Donegani, M. I.; Brugnolo, A.; Biassoni, E.; Mattioli, P.; Girtler, N.; Guerra, U. P.; Morbelli, S.; Nobili, F. | |
| Alzheimer's disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era | 1-gen-2024 | Sofia, Luca; Massa, Federico; Pardini, Matteo; Arnaldi, Dario; Bauckneht, Matteo; Morbelli, Silvia | |
| Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease | 1-gen-2020 | Orso, B.; Arnaldi, D.; Fama, F.; Girtler, N.; Brugnolo, A.; Doglione, E.; Filippi, L.; Massa, F.; Peira, E.; Bauckneht, M.; Morbelli, S.; Nobili, F.; Pardini, M. | |
| Anti-LGI1 encephalitis and Langerhans cell histiocytosis: two associated entities? A case report | 1-gen-2024 | Cerne, Denise; Massa, Federico; Mora, Marco; Morbelli, Silvia; Roccatagliata, Luca; Rebella, Giacomo; Villani, Flavio; Bozzano, Federica; Uccelli, Antonio; Benedetti, Luana; Cabona, Corrado | |
| Autoimmune encephalitis: what the radiologist needs to know | 1-gen-2024 | Sanvito, F.; Pichiecchio, A.; Paoletti, M.; Rebella, G.; Resaz, M.; Benedetti, L.; Massa, F.; Morbelli, S.; Caverzasi, E.; Asteggiano, C.; Businaro, P.; Masciocchi, S.; Castellan, L.; Franciotta, D.; Gastaldi, M.; Roccatagliata, L. | |
| Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. | 1-gen-2020 | Massa, F; Zuppa, A; Pesce, G; Demichelis, C; Bergamaschi, M; Garnero, M; Briani, C; Ferrari, S; Schenone, A; Benedetti, L | |
| Brain metabolic correlates of persistent olfactory dysfunction after sars-cov2 infection | 1-gen-2021 | Donegani, M. I.; Miceli, A.; Pardini, M.; Bauckneht, M.; Chiola, S.; Pennone, M.; Marini, C.; Massa, F.; Raffa, S.; Ferrarazzo, G.; Arnaldi, D.; Sambuceti, G.; Nobili, F.; Morbelli, S. | |
| Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) | 1-gen-2021 | Brugnolo, Andrea; Girtler, Nicola; Doglione, Elisa; Orso, Beatrice; Massa, Federico; Donegani, Maria Isabella; Bauckneht, Matteo; Morbelli, Silvia; Arnaldi, Dario; Nobili, Flavio; Pardini, Matteo | |
| Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS | 1-gen-2022 | Bellucci, Margherita; Germano, Francesco; Grisanti, Stefano; Castellano, Chiara; Tazza, Francesco; Mobilia, Emanuela Maria; Visigalli, Davide; Novi, Giovanni; Massa, Federico; Rossi, Silvia; Durando, Paolo; Cabona, Corrado; Schenone, Angelo; Franciotta, Diego; Benedetti, Luana | |
| Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease | 1-gen-2023 | Massa, F.; Martinuzzo, C.; Gomez de San Jose, N.; Pelagotti, V.; Kreshpa, W.; Abu-Rumeileh, S.; Barba, L.; Mattioli, P.; Orso, B.; Brugnolo, A.; Girtler, N.; Vigo, T.; Arnaldi, D.; Serrati, C.; Uccelli, A.; Morbelli, S.; Chincarini, A.; Otto, M.; Pardini, M. | |
| Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease | 1-gen-2022 | Barba, L.; Abu Rumeileh, S.; Bellomo, G.; Paolini Paoletti, F.; Halbgebauer, S.; Oeckl, P.; Steinacker, P.; Massa, F.; Gaetani, L.; Parnetti, L.; Otto, M. | |
| Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease | 1-gen-2024 | Barba, Lorenzo; Abu-Rumeileh, Samir; Barthel, Henryk; Massa, Federico; Foschi, Matteo; Bellomo, Giovanni; Gaetani, Lorenzo; Rudolf Thal, Dietmar; Parnetti, Lucilla; Otto, Markus | |
| Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia | 1-gen-2020 | Orso, B; Mattei, C; Arnaldi, D; Massa, F; Serafini, G; Plantone, D; Doglione, E; Grafman, J; Nobili, F; Pardini, M. | |
| Clinical utility and research frontiers of neuroimaging in movement disorders | 1-gen-2017 | Nobili, FLAVIO MARIANO; Westman, Eric; Kogan, Rosalie V; Pereira, Joana B; Massa, Federico; Grazzini, Matteo; Meles, Sanne K; Leenders, Klaus L. | |
| Clinical versus biomarker-based diagnosis of neurocognitive disorders – Authors' reply | 1-gen-2024 | Massa, F.; Villain, N.; Cotta Ramusino, M.; Frisoni, G. B. | |
| Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy | 1-gen-2022 | Mattioli, Pietro; Pardini, Matteo; Girtler, NICOLA GIOVANNI; Brugnolo, Andrea; Orso, Beatrice; Donniaquio, Andrea; Calizzano, Francesco; Mancini, Raffaele; Massa, Federico; Terzaghi, Michele; Bauckneht, Matteo; Morbelli, SILVIA DANIELA; Sambuceti, Gianmario; Nobili, FLAVIO MARIANO; Arnaldi, Dario |